AI
COYA icon

Atom Investors’s Coya Therapeutics COYA Stock Holding History

Atom Investors’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20,081
Closed -$115K – 640
2025
Q2 		$115K Buy
20,081
+356
+2% +$2.06K 0.01% 543
2025
Q1 		$128K Buy
19,725
+5,449
+38% +$34.5K 0.02% 422
2024
Q4 		$81.8K Buy
+14,276
New +$97.2K 0.01% 456

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Atom Investors's COYA Position: Q3 2025 in Review

Atom Investors sold out of Coya Therapeutics (COYA) in Q3 2025, closing a stake of 20,081 shares — an estimated $115K sold.

Atom Investors first reported a position in COYA in Q4 2024 and held it in 3 quarters. The position peaked at $128K in Q1 2025. 36 funds tracked by Wall St. Rank hold COYA as of Q3 2025.

  • Atom Investors reported no remaining Coya Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Atom Investors sold 20,081 Coya Therapeutics shares in Q3 2025, an estimated $115K.
  • Atom Investors first reported a position in Coya Therapeutics in Q4 2024 and held it in 3 quarters.
  • Atom Investors's Coya Therapeutics position peaked at $128K in Q1 2025.
  • 36 funds tracked by Wall St. Rank held Coya Therapeutics as of Q3 2025.

Based on Atom Investors's 13F filing for Q3 2025, filed 14 Nov 2025.